Est. 2001·3,000+ placements · six offices · four regions
Ma Activitycurated sourcedetected 2026-04-30 · confidence 90%

Last updated

Version 1: Ma Activity

Version 1 acquired CreateFuture, creating a €500m digital transformation powerhouse with 4,250 employees

Source: BusinessCloud UK

The leadership read

Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in sales.

Market context: Against a Talent Market Index of 111.1 (Hot) (up 5.2 month-on-month), EMEA is at easing (-4.4pts) on signal share.

Version 1: 1 signal in the last 90 days — in line with the Sales median of 1 across 25 tracked companies; 0.1% of MitchelLake's EMEA signal flow.

MitchelLake in this thematic

From the MitchelLake archive

More signals across Sales

Ma Activity · EMEA

Datadog

Datadog acquired Adaptive ML to accelerate AI R&D capabilities. The acquisition will integrate Adaptive ML into Datadog's AI lab to build frontier AI infrastructure for observability and security research.

Partnership · EMEA

Trustpilot

Trustpilot integrated customer review functionality into Shopify stores, expanding distribution and embedded review capabilities.

Partnership · EMEA

NICE Actimize

NICE Actimize won a major mandate with DNB Bank ASA (Norway's largest financial services group) to deploy X-Sight Enterprise platform for fraud and financial crime detection. Infosys selected as systems integration partner for end-to-end modernization.

Partnership · EMEA

Napier AI

Napier AI partnered with Concentrix to expand its Continuum compliance platform into ANZ markets, leveraging Concentrix's scale and transformation expertise to serve financial services organizations.

Capital Raising · EMEA

Liftoff Mobile

Liftoff Mobile completed IPO on Nasdaq, raising $437 million. CEO Jeremy Bondy led the company public after market stabilization, achieving tenth consecutive quarter of growth. Backed by Blackstone private equity.

Product Launch · EMEA

Novo Nordisk

Novo Nordisk's investigational zenagamtide (once-weekly GLP-1 receptor agonist) demonstrated significant A1C reductions and up to 14.6% weight loss in Phase 2 study of adults with type 2 diabetes, presented at ADA 2026

Weekly briefing

Track companies like Version 1 — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Share: WhatsApp · X · Email